Cell Reports
Volume 39, Issue 2, 12 April 2022, 110650
Journal home page for Cell Reports

Article
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells

https://doi.org/10.1016/j.celrep.2022.110650Get rights and content
Under a Creative Commons license
open access

Highlights

  • Cell-to-cell spread makes resting CD4+ T cells permissive to HIV-1 infection

  • Resting memory T cells are productively infected by HIV-1

  • HIV-1 Vpr drives resting memory T cells to gain characteristics of tissue residency

  • Vpr induces widespread transcriptional reprogramming of infected T cells

Summary

HIV-1 replicates in CD4+ T cells, leading to AIDS. Determining how HIV-1 shapes its niche to create a permissive environment is central to informing efforts to limit pathogenesis, disturb reservoirs, and achieve a cure. A key roadblock in understanding HIV-T cell interactions is the requirement to activate T cells in vitro to make them permissive to infection. This dramatically alters T cell biology and virus-host interactions. Here we show that HIV-1 cell-to-cell spread permits efficient, productive infection of resting memory T cells without prior activation. Strikingly, we find that HIV-1 infection primes resting T cells to gain characteristics of tissue-resident memory T cells (TRM), including upregulating key surface markers and the transcription factor Blimp-1 and inducing a transcriptional program overlapping the core TRM transcriptional signature. This reprogramming is driven by Vpr and requires Vpr packaging into virions and manipulation of STAT5. Thus, HIV-1 reprograms resting T cells, with implications for viral replication and persistence.

Keywords

HIV-1
Vpr
resting memory T cell
cell-cell
tissue residency
permissivity
transcriptional reprogramming

Research topics

CP: Microbiology
CP: Immunology

Data and code availability

  • RNA-Seq data have been deposited at ArrayExpress and are publicly available as of the date of publication. This paper analyses existing, publicly available data. Accession numbers for all datasets are listed in the key resources table.

  • This paper does not report original code.

  • Any additional information required to reanalyse data reported in this paper is available from the lead contact upon request.

Cited by (0)

10

Present address: Leicester School of Pharmacy, De Montfort University, Leicester LE1 9BH, UK

11

These authors contributed equally

12

Lead contact